Research Lab of David Auerbach PhD
Dr. David S. Auerbach, PhD
Location: Upstate Medical University
5292 Weiskotten Hall, Syracuse, NY 13210
Phone: 315-464-7952
Email: auerbacd@upstate.edu
Location: Upstate Medical University
5292 Weiskotten Hall, Syracuse, NY 13210
Phone: 315-464-7952
Email: auerbacd@upstate.edu
The Auerbach Lab strives for a scientifically productive environment, through providing an inclusive and collegial environment for people to work together to advance our understanding of neuro-cardiac electrical disturbances. The group works together to mentor younger scientists, teach others new scientific approaches, and promote scientifically sound and reproducible results.
Bedside to Bench to Bedside Research Approach
Multi-System Approach to Understanding and Treating Genetic Ion Channel Diseases: The Auerbach Lab’s “Bedside-to-Bench-to-Bedside” approach to research involves clinical studies of humans with a history of electrical disturbances in the brain (seizures/epilepsy) and heart (arrhythmias). Additionally, we generated a genetic rabbit model of an inherited cardiac arrhythmia disease. It enables us to explore the underlying causes for these abnormalities by performing experiments at the molecular, biochemical, cellular, and whole animal levels. Each aspect of the research program feeds and motivates the others, creating a productive research cycle.
Recent News
- December 2022: David Auerbach is awarded a Clinical Research Grant by the Dravet Syndrome Foundation: Genetic Substrates and Physiological Triggers for Autonomic and Cardiac Abnormalities in Dravet Syndrome
- December 2022: David Auerbach, Lou Adebiyi, Kyle Wagner, Justin Ryan, and Veronica Singh presented at the 2022 American Epilepsy Society (AES) and Partners Against Mortality in Epilepsy (PAME) annual meetings in Nashville, TN.
- September 2022: Veronica Singh wins first prize best poster at the SUNY Upstate Biomedical Sciences Retreat.
- August 2022: Lou Adebiyi is awarded a Young Investigator Award by the American Epilepsy Society.
Funding Partners
